Newsroom
Sorted by: Latest
-
OpenAI's GPT-6.1 Terra Is Fast and Cheap but Trails Leading AI Models on Accounting Work, DualEntry Benchmark Finds
NEW YORK--(BUSINESS WIRE)--OpenAI's newly released GPT-6.1 Terra scored 78.2% on the DualEntry Accounting AI Benchmark, tying for 18th among 22 leading AI models tested. The model performed strongest in transaction classification and journal entries. But weaker results in accounts payable and accounts receivable left it behind Google's Gemini 4 Argon at 91.1%, Zhipu AI's GLM-5.3 Flash at 88.1% and SpaceXAI's Grok 4.7 at 88.1%. It also trails OpenAI's own GPT-6.1 Sol, which scored 81.2%. Where T...
-
North Haven Private Income Fund LLC Enters Into Merger Agreement With North Haven Private Income Fund A LLC
NEW YORK--(BUSINESS WIRE)--North Haven Private Income Fund LLC (“PIF”) and North Haven Private Income Fund A LLC (“PIF A” and each of PIF and PIF A, a “Company” and together, the “Companies”), each a business development company externally managed by MS Capital Partners Adviser Inc. (the “Adviser”), announced today that PIF has entered into a merger agreement with PIF A (the “Merger Agreement”), pursuant to which PIF A would merge with and into PIF (the “Merger”) with Class I unitholders of PIF...
-
Arcus Biosciences Announces New Employment Inducement Grants
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for the treatment of cancer and immune diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted three new employees options to purchase a total of 10,650 shares of the Company’s common stock at an exercise price per share of $18.54, which was the closing price...
-
Intel to Acquire Classiq to Create a Full-stack Quantum Computing Platform
SANTA CLARA, Calif. & TEL AVIV, Israel--(BUSINESS WIRE)--Intel to Acquire Classiq to Create a Full-stack Quantum Computing Platform...
-
Sarepta Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in the following upcoming investor conferences on Nov. 9, 2026:8th Annual Wolfe Research Healthcare Conference in New York CityGuggenheim Securities 3rd Annual Healthcare Innovation Conference in BostonFireside chat: 3 p.m. ETThe presentation from the Guggenheim conference will be webcast live under the in...
-
Better Home & Finance Holding Company to Announce Third Quarter 2026 Results on November 9, 2026
NEW YORK--(BUSINESS WIRE)--Better Home & Finance Holding Company (NASDAQ: BETR; BETRW) (“Better” or the “Company”) today announced that the Company will issue its third quarter 2026 results after market close on Monday, November 9, 2026. Leadership will host a conference call and webcast to discuss results at 4:30 pm. ET. A press release detailing the Company’s results will be issued prior to the call. Details to register for the live webcast and to listen to the call by phone will be avail...
-
Q2 Holdings, Inc. Presents: Agentic Banking & the Fraud Advantage – A Conversation with Q2’s CTO & COO | Investor Briefing
AUSTIN, Texas--(BUSINESS WIRE)--Q2 Holdings, Inc. (NYSE: QTWO), a leading provider of digital transformation solutions for financial services, published an investor briefing video titled “Agentic Banking & the Fraud Advantage: A Conversation with Q2’s CTO & COO | Investor Briefing,” available on the Company’s Events & Presentations page of its Investor Relations website. In the briefing, Q2 Chief Technology Officer Adam Blue and Q2 Chief Operating Officer Hima Mukkamala discuss how...
-
FirstSun Capital Bancorp Reports Third Quarter 2026 Results
DENVER--(BUSINESS WIRE)--FirstSun Capital Bancorp (“FirstSun”) (NASDAQ: FSUN) reported net income of $38.4 million in the third quarter of 2026 compared to net income of $23.2 million in the third quarter of 2025. Earnings per diluted share were $0.82 in both the third quarter of 2026 and 2025. Adjusted net income, a non-GAAP financial measure, was $48.2 million or $1.03 per diluted share in the third quarter of 2026 compared to $23.4 million or $0.83 per diluted share in the third quarter of 2...
-
Materion Corporation Declares Quarterly Cash Dividend
MAYFIELD HEIGHTS, Ohio--(BUSINESS WIRE)--Materion Corporation (NYSE: MTRN) announced today that its Board of Directors declared a fourth-quarter 2026 dividend of $0.145 per share of common stock. The dividend is payable on December 4, 2026, to shareholders of record at the close of business on November 19, 2026. About Materion Materion Corporation is a global leader in advanced materials solutions for high-performance industries including semiconductor, industrial, aerospace & defense, ener...
-
Bain Capital Specialty Finance, Inc. Schedules Earnings Release for the Third Quarter Ended September 30, 2026
BOSTON--(BUSINESS WIRE)--Bain Capital Specialty Finance, Inc. (NYSE: BCSF, the “Company”, “our” or “we”) today announced it will report its financial results for the third quarter ended September 30, 2026 on Monday, November 9, 2026 after market close. Management will host a conference call on Tuesday, November 10, 2026 at 10:00 a.m. Eastern Time to discuss the Company’s financial results. Conference Call Information A conference call to discuss the Company’s financial results will be held live...